Clinical Trials Logo

Drug Induced Dyskinesia clinical trials

View clinical trials related to Drug Induced Dyskinesia.

Filter by:
  • None
  • Page 1

NCT ID: NCT01789047 Terminated - Clinical trials for Idiopathic Parkinson's Disease

Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

TOP-DYSK
Start date: March 2013
Phase: Phase 2
Study type: Interventional

The study will involve an eighteen-week, double-blind, placebo-controlled parallel designed comparison between add-on topiramate and add-on placebo to stable treatment with amatadine in the treatment of Parkinson's disease (PD) patients who continue to have dyskinesia on amantadine.